measured using homogenates of cerebral cortex including hippocampus as
previously described [22 (link)–24 (link)]. Briefly, sections of cerebral cortex
were homogenized in Cell Lysis buffer (Cell Signaling Technology). Homogenates
containing 50 μg of protein were used for complex I (NADH-ubiquinone
oxidoreductase) and IV (cytochrome c oxidase) assays. Complex I activity was
determined in 25 mM potassium buffer containing 3 M KCl, 1 M Tris-HCl, and 0.5 M
EDTA (pH 7.4). The change in absorbance was monitored at 340 nm wavelength every
20 s for 6 min using an Amersham Biosciences Ultrospect 3100 pro
spectrophotometer. Complex IV activity was determined by cytochrome c reduction
rate. Briefly, the protein samples were added to a cuvette containing 0.475 ml
of assay buffer (10 mM Tris-HCL, pH 7.0, and 120 mM KCl), and the reaction
volume was brought to 0.525 ml with enzyme dilution buffer (10 mM Tris-HCl, pH
7.0 and 250 mM sucrose). The reaction was initiated by the addition of
ferrocytochrome c substrate solution (0.22 mM) into the cuvette. The rate of
change in absorbance at 550 nm was recorded using a kinetic program with 5 s
delay and 10 s intervals for 6 readings on Amersham Biosciences Ultrospect 3100
pro spectrophotometer.